Kewaunee Scientific (KEQU) Cash from Financing Activities (2010 - 2026)

Kewaunee Scientific's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$2.9 million for Q2 2026.

• In Q2 2026, Cash from Financing Activities rose 32.0% year-over-year to -$2.9 million; the TTM figure through Apr 2026 stood at -$19.3 million (down 360.77% YoY), while the FY2026 annual figure was -$19.3 million, down 360.77% from the prior year.
• Cash from Financing Activities for Q2 2026 stood at -$2.9 million, up from -$14.1 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $14.6 million in Q1 2025, with the low at -$14.1 million in Q1 2026.
• The 5-year median for Cash from Financing Activities is -$1.2 million (2025), against an average of $232000.0.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities surged 639.31% in 2023, then tumbled 526.53% in 2025.
• Kewaunee Scientific's Cash from Financing Activities stood at -$145000.0 in 2022, then soared by 639.31% to $782000.0 in 2023, then plunged by 512.92% to -$3.2 million in 2024, then jumped by 73.58% to -$853000.0 in 2025, then slumped by 245.84% to -$2.9 million in 2026.
• Business Quant data shows KEQU's Cash from Financing Activities at -$2.9 million in Q2 2026, -$14.1 million in Q1 2026, and -$853000.0 in Q4 2025.